Calver Pang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Calver Pang | Medicine and Dentistry | Best Researcher Award

Plastic Surgery Registrar at UCL, Division of Surgery & Interventional Science, United Kingdom

Dr. Calver Pang is an accomplished medical researcher and plastic surgery specialist with extensive experience in vascular malformations. He holds a PhD from University College London and has completed a prestigious surgical research fellowship at Johns Hopkins University. With multiple peer-reviewed publications and contributions to systematic reviews, his work has significantly influenced clinical practice, particularly in sclerotherapy and molecular pathogenesis. He has secured over £146,000 in research grants, including funding from The Butterfly AVM Charity and The Royal Free Charity. Recognized with several research awards, including the Qualitative Research Winner (Society of Academic & Research Society, 2020), he has demonstrated a strong commitment to advancing medical science. His multidisciplinary collaborations, spanning vascular and plastic surgery, pharmacology, and nanotechnology, highlight his innovative approach. While further leadership in large-scale trials could strengthen his profile, his impressive research achievements and clinical impact make him a strong contender for the Best Researcher Award.

Professional Profile 

Education

Dr. Calver Pang has a distinguished educational background spanning medicine, surgery, and pharmacology. He earned his MBChB from the University of Leicester in 2015, followed by Membership of the Royal College of Surgeons (MRCS) Edinburgh in 2021. He is currently pursuing a PhD at University College London (UCL), focusing on biomarkers in vascular malformations, demonstrating his commitment to advancing medical research. Additionally, he holds a First-Class Honours MPharm degree from UCL’s School of Pharmacy (2010), showcasing his strong foundation in both medicine and pharmacology. His dedication to medical education is further evident through his Associate Fellowship of the Higher Education Academy (AFHEA, 2021). Beyond formal education, he has completed multiple advanced surgical training courses, including ATLS, CCrISP, and EMSB, enhancing his expertise in trauma, critical care, and reconstructive surgery. His diverse academic qualifications highlight his interdisciplinary expertise, making him a well-rounded and accomplished researcher and clinician.

Professional Experience

Dr. Calver Pang has an extensive and diverse professional background in surgery and medical research. Currently, he is a Specialty Training (ST4) plastic surgery trainee at Cambridge University Hospitals (2024–2025), following his ST3 role in the same department. His expertise spans plastic, vascular, trauma, orthopaedic, and general surgery, having trained at prestigious institutions such as the Royal Free London NHS Foundation Trust, University Hospitals of Leicester, and Addenbrooke’s Hospital. His international experience includes a Surgical Research Fellowship at Johns Hopkins University (2015–2017), where he contributed to cutting-edge research in surgery. Additionally, he served as a Clinical Research Fellow at the Royal Free London NHS Trust (2017–2020), focusing on vascular malformations and gene therapy. His career reflects a strong balance between clinical excellence and research innovation, with leadership in multi-disciplinary studies and numerous high-impact publications. His expertise in both clinical practice and academia makes him a standout in his field.

Research Interest

Mr. Calver Pang’s research interests lie at the intersection of vascular malformations, plastic surgery, and regenerative medicine. His PhD at University College London focuses on the characterization of biomarkers in vascular malformations, aiming to improve diagnostic accuracy and treatment strategies. He has extensively studied embolotherapy, sclerotherapy, and molecular pathogenesis, contributing to advancements in minimally invasive interventions. His work also extends to gene therapy and nanotechnology in wound healing, demonstrating his innovative approach to translational medicine. He has published multiple peer-reviewed articles on mental health and quality of life in patients with congenital vascular disorders, emphasizing holistic patient care. Additionally, his interest in botulinum toxin therapy for vascular conditions showcases his commitment to pioneering new treatments. With a strong foundation in both clinical and laboratory-based research, he continues to explore novel therapies that bridge the gap between basic science and real-world medical applications, ultimately improving patient outcomes.

Award and Honor
Mr. Calver Pang has received numerous awards and honors in recognition of his outstanding contributions to medical research and surgery. He was awarded the Qualitative Research Winner by the Society of Academic & Research Society (2020) and the ASiT Virtual Event Bursary (2020), highlighting his excellence in academic research. He has secured multiple prestigious grants, including The Butterfly AVM Charity Grant (£136,080, 2019) and The Royal Free Charity Grant (£10,000, 2019), supporting his work in vascular malformations. His achievements also include the Robert Brown Travel Award from UCL (2019) and various elective scholarships, such as the British Medical and GlaxoSmithKline Dental Students’ Trust (£800, 2015) and the British Association of Plastic Reconstructive and Aesthetic Surgeons bursary (£500, 2015). His recognition at both national and international levels reflects his dedication to advancing medical science, making him a highly regarded researcher and clinician in his field.

Research Skill

Mr. Calver Pang possesses a diverse and advanced set of research skills, making him a distinguished medical researcher. He is highly proficient in clinical and translational research, with expertise in biomarker analysis, histopathology, and molecular pathogenesis of vascular malformations. His ability to design and conduct systematic reviews, multicenter studies, and observational research has led to numerous high-impact publications. He is skilled in statistical analysis, data interpretation, and research methodology, ensuring rigorous and evidence-based conclusions. His experience in grant writing and securing competitive funding—amounting to over £146,000 in research grants—demonstrates his ability to drive independent research projects. Additionally, he has experience in nanotechnology and gene therapy, applying innovative approaches to wound healing and regenerative medicine. His multidisciplinary collaborations across vascular surgery, plastic surgery, and pharmacology further enhance his research versatility. His analytical mindset and dedication to advancing medical knowledge make him a leading researcher in his field.

Conclusion

Mr. Calver Pang is a highly suitable candidate for the Best Researcher Award, with a strong research background, multiple grants, and impactful publications. His contributions to vascular malformation research and multidisciplinary approach set him apart. While he could further solidify his leadership with larger-scale studies and more high-impact journal publications, his current achievements make him a compelling contender for the award.

Publications Top Noted

  • Author(s): Pang, C., Iakovou, D., Fraser, D., Langridge, B.J., Butler, P.E.M.
  • Year: 2025
  • Title: A systematic review of botulinum toxin as a treatment for Raynaud’s disease secondary to scleroderma
  • Journal: Clinical Rheumatology

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Calogero Velluto | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Calogero Velluto | Medicine and Dentistry | Best Researcher Award

MD at Università cattolica del sacro cuore, roma, Italy

Dr. Calogero Velluto is a distinguished spine surgeon and researcher specializing in orthopedic and oncological sciences. His expertise lies in spinal surgery, minimally invasive techniques, and oncological spine disorders. He has contributed significantly to the field through numerous research publications, international fellowships, and active participation in prestigious medical societies. Dr. Velluto’s academic journey, extensive clinical experience, and commitment to advancing spinal surgery through research make him a notable candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Velluto earned his degree in Medicine and Surgery from the Università degli Studi di Messina in 2018, graduating with honors. He obtained his medical license in 2019 and completed a residency in Orthopedic Surgery at Università Cattolica del Sacro Cuore in 2024. Currently, he is pursuing a Ph.D. in Oncological Sciences at the same university. Additionally, he has attended specialized training programs such as the AO Spine Course and Spine Academy.

Professional Experience

Dr. Velluto has held key roles in spine surgery at Fondazione Policlinico Universitario A. Gemelli IRCCS. He completed an international research fellowship at the San Diego Spine Foundation and underwent mentorship at Mayo Clinic. His experience includes pediatric orthopedic surgery at Ospedale Pediatrico Bambino Gesù and emergency medicine in Messina. As a dedicated researcher, he has published extensively on spinal deformities, fracture treatments, and minimally invasive spine surgery techniques.

Research Interests

Dr. Calogero Velluto’s research focuses on spinal surgery, minimally invasive techniques, and oncological spine disorders. His primary interests include spinal deformities, vertebral fractures, and advanced surgical treatments for spinal tumors. He actively investigates innovative approaches to enhance surgical outcomes, optimize recovery, and improve the quality of life for patients with complex spinal conditions. Additionally, he is involved in clinical studies exploring novel biomaterials and implants for spine stabilization. His research contributions aim to bridge the gap between surgical practice and cutting-edge medical advancements.

Awards and Honors

Dr. Velluto has received multiple accolades for his contributions to orthopedic and spine surgery. He was awarded the Best Paper Presentation at international spine conferences and has been recognized for his outstanding research in spinal oncology. His participation in prestigious fellowships, such as the San Diego Spine Foundation Research Fellowship, highlights his excellence in spine surgery. His work has earned recognition from renowned medical societies and academic institutions.

Research Skills

Dr. Velluto possesses a strong skill set in clinical and experimental research, particularly in orthopedic and spinal surgery. He is proficient in biomechanical testing, data analysis, and statistical modeling for surgical outcomes. His expertise extends to advanced imaging techniques, including MRI and CT-based diagnostic evaluations. He has significant experience in conducting systematic reviews, writing scientific publications, and collaborating on multi-institutional studies. His ability to integrate research with clinical practice allows him to develop innovative, evidence-based treatment approaches in spinal surgery.

Conclusion

Calogero Velluto is a strong candidate for the Best Researcher Award, given his extensive research contributions, international collaborations, and academic excellence in spine surgery. To further strengthen his candidacy, he should focus on increasing his research impact through higher citation metrics, securing independent funding, and diversifying his research portfolio.

Publications Top Noted

  • Title: Incidence and Risk Assessment of Acute Kidney Injury (AKI) in Spine Surgery: A Case Report and Literature Review
    Authors: Calogero Velluto, Giovan Giuseppe Mazzella, Laura Scaramuzzo, Maria Ilaria Borruto, Michele Inverso, Lorenzo Fulli, Matteo Costanzi, Marco Rossi, Luca Proietti
    Year: 2025
    Citation: Journal of Clinical Medicine, DOI: 10.3390/jcm14041210

  • Title: Epidemiology, Diagnosis, Management, and Prognosis of Spinal Metastasis: The State-of-the-Art
    Authors: Andrea Perna, Calogero Velluto, Amarildo Smakaj, Maria Concetta Meluzio, Maria Ilaria Borruto, Raffaele Vitiello, Giulio Maccauro, Andrea Franchini, Franco Lucio Gorgoglione, Luca Proietti
    Year: 2024
    Citation: Book chapter, DOI: 10.1007/16833_2024_304

  • Title: Impact of a Novel Antiseptic Lavage Solution on Acute Periprosthetic Joint Infection in Hip and Knee Arthroplasty
    Authors: Luca Andriollo, Rudy Sangaletti, Calogero Velluto, Loris Perticarini, Francesco Benazzo, Stefano Marco Paolo Rossi
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13113092

  • Title: Radiological Evaluation of Fusion Patterns After Lateral Lumbar Interbody Fusion With 3D-Printed Porous Titanium Cages vs. Conventional Titanium Cages
    Authors: Calogero Velluto, Gregory Mundis Jr, Laura Scaramuzzo, Andrea Perna, Giacomo Capece, Andrea Cruciani, Michele Inverso, Maria Ilaria Borruto, Luca Proietti
    Year: 2024
    Citation: Frontiers in Surgery, DOI: 10.3389/FSURG.2024.1446792

  • Title: Rethinking Strategies for Multi-Metastatic Patients: A Comprehensive Retrospective Analysis on Open Posterior Fusion Versus Percutaneous Osteosynthesis in the Treatment of Vertebral Metastases
    Authors: Laura Scaramuzzo, Andrea Perna, Calogero Velluto, Maria Ilaria Borruto, Franco Lucio Gorgoglione, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13113343

  • Title: The Incidence of Screw Failure in Fenestrated Polyaxial Pedicle Screws vs. Conventional Pedicle Screws in the Treatment of Adolescent Idiopathic Scoliosis (AIS)
    Authors: Calogero Velluto, Michele Inverso, Maria Ilaria Borruto, Andrea Perna, Guido Bocchino, Davide Messina, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13061760

  • Title: The Use of an Imageless Robotic System in Revision of Unicompartmental Knee Arthroplasty
    Authors: Luca Andriollo, Francesco Benazzo, Virgina Cinelli, Rudy Sangaletti, Calogero Velluto, Stefano Marco Paolo Rossi
    Year: 2024
    Citation: Knee Surgery, Sports Traumatology, Arthroscopy, DOI: 10.1002/ksa.12574

  • Title: Enhancing MRI Report Comprehension in Spinal Trauma: An Analysis of AI-Generated Explanations for Thoracolumbar Fractures (Preprint)
    Authors: David C. Sing, Kishan S. Shah, Michael Pompliano, Paul H. Yi, Calogero Velluto, Ali Bagheri, Robert K. Eastlack, Stephen Stephan, Gregory M. Mundis
    Year: 2024
    Citation: DOI: 10.2196/preprints.69654

  • Title: Clinical and Radiographic Results in Thoracic Hyperkyphosis Surgical Treatment Considering the Optimal Distal Fusion Area
    Authors: Laura Scaramuzzo, Fabrizio Giudici, Calogero Velluto, Giuseppe Barone, Maria Concetta Meluzio, Antonino Zagra, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/jcm13226799

Jian Zhou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Jian Zhou | Medicine and Dentistry | Best Researcher Award

Zhongshan hospital, fudan university, China

Dr. Jian Zhou is an Associate Chief Physician in the Department of Orthopedics at Zhongshan Hospital, Fudan University, specializing in spinal surgery, minimally invasive techniques, and bone defect repair. With a Ph.D. in Orthopedics and over a decade of experience, he has led multiple national and provincial research projects, securing competitive grants such as the National Natural Science Foundation of China Youth Fund. His research has resulted in numerous high-impact SCI-indexed publications and several patented innovations in orthopedic surgery. Recognized with prestigious awards, including the National Science and Technology Progress Award, Dr. Zhou is also actively involved in professional committees and serves as an AO Spine Young Faculty. His contributions to orthopedic advancements, particularly in biomaterials and surgical techniques, have significantly influenced spinal surgery practices. While his impact is well-established in China, expanding global collaborations and publishing in top-tier international journals could further enhance his research influence worldwide.

Professional Profile 

Education

Dr. Jian Zhou obtained his Bachelor of Clinical Medicine degree from China Medical University in 2006, laying a strong foundation in medical sciences. He then pursued a Ph.D. in Orthopedics at Zhongshan Hospital, Fudan University, from 2006 to 2011, where he specialized in spinal surgery, minimally invasive techniques, and bone defect repair. His doctoral research focused on innovative orthopedic treatments, particularly in biomaterials and regenerative medicine. Throughout his academic journey, Dr. Zhou demonstrated exceptional research capabilities, earning recognition for his contributions to orthopedic advancements. His education provided him with in-depth expertise in both basic and clinical research, enabling him to develop novel surgical techniques and therapeutic approaches for spinal disorders. His academic excellence was further acknowledged through prestigious awards, including Fudan University’s Outstanding Dissertation Award and Academic Star recognition, solidifying his reputation as a dedicated researcher and clinician in the field of orthopedic surgery.

Professional Experience

Dr. Jian Zhou has built a distinguished career in orthopedic surgery at Zhongshan Hospital, Fudan University. He began as a Resident Physician in the Department of Surgery in 2011 before transitioning to the Department of Orthopedics in 2012. In 2013, he was promoted to Attending Physician, where he gained extensive experience in spinal surgery, minimally invasive techniques, and bone defect repair. His dedication and expertise led to his appointment as an Associate Chief Physician in 2018, a role in which he continues to advance surgical innovations and mentor young medical professionals. Over the years, Dr. Zhou has played a crucial role in pioneering new surgical methods, securing research funding, and contributing to national and international orthopedic advancements. His professional journey reflects a commitment to excellence in patient care, medical research, and academic leadership, making him a recognized figure in the field of spinal and orthopedic surgery.

Research Interest

Dr. Jian Zhou’s research interests focus on spinal surgery, minimally invasive spine techniques, and bone defect repair, integrating both basic and clinical research to develop innovative orthopedic treatments. He has dedicated his work to advancing biomaterials for bone regeneration, particularly in the development of antibiotic-eluting bone substitutes and nano-silver composite scaffolds for infected bone defects. His research also explores tumor-related spinal conditions, including surgical strategies for spinal metastases and optimizing blood loss management in complex spinal procedures. Through various national and provincial research grants, Dr. Zhou has contributed significantly to orthopedic biomaterial innovation, helping improve patient outcomes in spinal reconstruction and fracture healing. His work extends to tissue engineering and regenerative medicine, where he investigates novel approaches to enhance spinal fusion and cartilage repair. With numerous high-impact publications and patents, Dr. Zhou continues to push the boundaries of orthopedic research, aiming for safer and more effective surgical solutions.

Award and Honor

Dr. Jian Zhou has received numerous prestigious awards and honors in recognition of his contributions to orthopedic research and innovation. He was awarded the National Science and Technology Progress Award (Second Class) in 2014 and the Shanghai Science and Technology Progress Award (First and Second Class) for his groundbreaking work in spinal surgery and biomaterials. His achievements also include the Shanghai Medical Science and Technology Award and the Science and Technology Award from the Chinese Association for Laboratory Animal Sciences. As a testament to his early academic excellence, he was named a Shanghai Outstanding Graduate and received Fudan University’s Outstanding Dissertation Award. Additionally, he has been recognized as a Shanghai Rising-Star Scholar and a recipient of the Shanghai Outstanding Young Medical Talents Training Program. These accolades highlight his significant impact on orthopedic advancements, reinforcing his status as a leading researcher and clinician in spinal surgery.

Research Skill

Dr. Jian Zhou possesses strong research skills in orthopedic surgery, spinal reconstruction, and biomaterials innovation, combining clinical expertise with cutting-edge scientific inquiry. His ability to design and execute experimental studies is evident in his extensive work on antibiotic-eluting bone substitutes, nano-silver composite scaffolds, and minimally invasive spinal techniques. He has successfully secured and led multiple national and provincial research grants, showcasing his grant-writing proficiency and ability to drive impactful projects. His expertise in biomechanics, tissue engineering, and regenerative medicine enables him to develop novel approaches for bone defect repair and spinal tumor management. Additionally, his contributions to high-impact scientific publications demonstrate his data analysis, manuscript writing, and peer review skills. With several patents for innovative orthopedic devices, Dr. Zhou also excels in translational research, bridging the gap between laboratory discoveries and clinical applications. His comprehensive research skill set solidifies his role as a pioneer in spinal and orthopedic advancements.

Conclusion

Dr. Jian Zhou is a strong candidate for the Best Researcher Award due to his extensive contributions to spinal surgery research, innovative approaches to bone defect repair, and recognition through prestigious awards and grants. While he could enhance his profile through greater international collaborations and higher impact publications, his current credentials make him highly deserving of such an honor.

Publications Top Noted

  • Functional Silver‐Loaded Porous Composite Scaffold for Bone Tissue Bacterial Infection
    Authors: An’nan Hu, Jian Zhou
    Year: 2025
    DOI: 10.1002/anbr.202500004

  • Anterior cervical discectomy and fusion with self-locking standalone cage for the treatment of cervical degenerative disc disease in patients over 80 years
    Authors: Jian Zhou, Hu An, Zhou XG, Dong J
    Year: 2025
    DOI: 10.1186/s10195-025-00820-7

  • Computed Tomography Perfusion Combined With Preoperative Embolization for Reducing Intraoperative Blood Loss in Separation Surgery for Thoracolumbar Metastases
    Authors: Jian Zhou, Yi Zhou, Sheng Qian, Xilei Li, Hong Lin, Jian Dong, Xiaogang Zhou
    Year: 2024
    DOI: 10.1097/brs.0000000000004780

  • Engineering BPQDs/PLGA nanospheres-integrated wood hydrogel bionic scaffold for combinatory bone repair and osteolytic tumor therapy
    Authors: Zhichao Hu, Jiaqi Lu, An’nan Hu, Yongjiang Dou, Sheng Wang, Dihan Su, Wang Ding, Ruixian Lian, Shunyi Lu, Lan Xiao et al.
    Year: 2022
    DOI: 10.1016/j.cej.2022.137269

  • Could self-locking stand-alone cage reduce adjacent-level ossification development after anterior cervical discectomy and fusion?
    Authors: Jian Zhou, Juan Li, Hong Lin, Xilei Li, Jian Dong, Xiaogang Zhou
    Year: 2020
    DOI: 10.1016/j.jocn.2020.06.014

  • A comparison of a self-locking stand-alone cage and anterior cervical plate for ACDF: Minimum 3-year assessment of radiographic and clinical outcomes
    Authors: Jian Zhou, Juan Li, Hong Lin, Xilei Li, Xiaogang Zhou, Jian Dong
    Year: 2018
    DOI: 10.1016/j.clineuro.2018.04.033

  • Treatment of osteomyelitis defects by a vancomycin-loaded gelatin/β-tricalcium phosphate composite scaffold
    Authors: J. Zhou, X. G. Zhou, J. W. Wang, H. Zhou, J. Dong
    Year: 2018
    DOI: 10.1302/2046-3758.71.bjr-2017-0129.r2

  • Anterior decompression and hybrid reconstruction with titanium mesh cage plus plate and self-locking stand-alone cage for the treatment of three-level cervical spondylotic myelopathy
    Authors: Jian Zhou, Xilei Li, Xiaogang Zhou, Hong Lin, Jian Dong
    Year: 2017
    DOI: 10.1016/j.jocn.2017.04.022

  • Tissue-engineered cartilage constructed by a biotin-conjugated anti-CD44 avidin binding technique for the repairing of cartilage defects in the weight-bearing area of knee joints in pigs
    Authors: H. Lin, J. Zhou, L. Cao, H.R. Wang, J. Dong, Z.R. Chen
    Year: 2017
    DOI: 10.1302/2046-3758.65.bjr-2016-0277

  • Biotin‐conjugated anti‐CD44 antibody–avidin binding system for the improvement of chondrocyte adhesion to scaffolds
    Authors: Hong Lin, Jian Zhou, Longxiang Shen, Yuhui Ruan, Jian Dong, Changan Guo, Zhengrong Chen
    Year: 2014
    DOI: 10.1002/jbm.a.34770

  • The controlled release of vancomycin in gelatin/β‐TCP composite scaffolds
    Authors: Jian Zhou, Taolin Fang, Yichao Wang, Jian Dong
    Year: 2012
    DOI: 10.1002/jbm.a.34170

Johannes Lässing | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Johannes Lässing | Health Professions | Best Researcher Award

Post doc at Martin Luther University Halle-Wittenberg, Germany

Dr. Johannes Lässing is a distinguished researcher in sports medicine and exercise physiology, currently serving as a research associate and head of sports medicine at Martin Luther University, Halle (Saale). With a Ph.D. (Dr. rer. med.) from the Medical Faculty of Leipzig, awarded magna cum laude, his research focuses on physiological adaptations to exercise, rehabilitation, and preventive healthcare. He has led multiple research projects on chronic metabolic diseases, post-COVID-19 return to sports, and dental protection in athletes. A prolific academic, he has reviewed for top-tier journals such as the European Respiratory Journal and Plos One, further establishing his credibility in the field. Dr. Lässing has also contributed to clinical trials and holds certifications in medical research ethics. His expertise extends to teaching biochemistry, physiology, and pathology in sports. With a strong research foundation, he continues to advance innovative solutions in sports science and rehabilitation.

Professional Profile 

Education

Dr. Johannes Lässing has a strong academic background in sports medicine and rehabilitation. He earned his Dr. rer. med. (Doctor of Medical Science) from the Medical Faculty of Leipzig in February 2022, achieving magna cum laude distinction. His doctoral research focused on the impact of individualized dental protection on cardiopulmonary, hormonal-metabolic parameters, and athletic performance. Prior to his Ph.D., he completed a Master of Science in Rehabilitation and Prevention from 2013 to 2016, further strengthening his expertise in sports medicine and health sciences. His education is complemented by specialized certifications, including advanced and basic courses for clinical investigators under the German Medical Association (AMG), as well as training in study direction for clinical trials. This robust educational foundation, combined with extensive research experience, has equipped Dr. Lässing with the knowledge and skills to contribute significantly to sports medicine, exercise physiology, and preventive healthcare.

Professional Experience

Dr. Johannes Lässing has extensive professional experience in sports medicine and research, currently serving as a research associate and head of sports medicine at Martin Luther University, Halle (Saale), since July 2022. Previously, he was a research associate at the Institute for Sports Medicine and Prevention (2017–2022), where he led multiple projects, including studies on acute physiological adaptations to dental protection, exercise interventions for chronic metabolic diseases, and telemonitoring-based health programs for cancer patients. He also spearheaded research on return-to-sport diagnostics after SARS-CoV-2 infection and strength training adaptations. From 2015 to 2020, he worked as a student and scientific assistant at the same institute, contributing to diabetes research. Additionally, he has served as a lecturer, teaching biochemistry, physiology, anatomy, and pathology in sports science. With expertise in clinical trials and medical diagnostics, Dr. Lässing continues to make significant contributions to exercise physiology and rehabilitation research.

Research Interest

Dr. Johannes Lässing’s research interests lie at the intersection of sports medicine, exercise physiology, and preventive healthcare. His work focuses on understanding the physiological and metabolic adaptations to exercise, with particular emphasis on rehabilitation, chronic disease management, and athletic performance. He has conducted research on exercise interventions for metabolic diseases, post-COVID-19 return-to-sport diagnostics, and the role of dental protection in physiological responses. Additionally, his studies explore the effects of strength training on acute physiological adaptations and the use of telemonitoring for cancer rehabilitation. His expertise extends to clinical trials, where he investigates innovative approaches to improving health outcomes through exercise-based interventions. Dr. Lässing is also interested in biochemistry and pathology in sports, aiming to bridge the gap between medical diagnostics and performance optimization. Through his research, he contributes to advancing knowledge in sports science, rehabilitation strategies, and preventive healthcare applications.

Award and Honor

Dr. Johannes Lässing has been recognized for his contributions to sports medicine and exercise physiology through various academic honors and research grants. He was awarded a prestigious research scholarship (Promotionsstipendium) from the European Social Fund (ESF) between 2017 and 2020, supporting his doctoral research on the impact of individualized dental protection on physiological and metabolic parameters in athletes. His Ph.D. from the Medical Faculty of Leipzig was conferred with magna cum laude distinction, highlighting the excellence of his research. Additionally, his work has been acknowledged through invitations to review for high-impact journals, such as the European Respiratory Journal and Journal of Science and Medicine in Sport. His leadership in multiple research projects at Martin Luther University further demonstrates his academic influence. With his growing impact in sports science and rehabilitation, Dr. Lässing continues to contribute significantly to the advancement of medical research in exercise and preventive healthcare.

Research Skill

Dr. Johannes Lässing possesses a diverse set of research skills in sports medicine, exercise physiology, and clinical trials. His expertise includes designing and leading interdisciplinary research projects focused on physiological adaptations to exercise, rehabilitation, and preventive healthcare. He is proficient in conducting clinical studies, with experience in medical diagnostics, telemonitoring, and self-management programs for chronic diseases and cancer rehabilitation. Dr. Lässing is skilled in data collection and analysis, utilizing advanced physiological and biochemical assessment techniques to study metabolic responses and performance adaptations. His ability to critically evaluate scientific literature is reflected in his role as a reviewer for high-impact journals. Additionally, he has strong teaching and mentorship skills, educating students in biochemistry, physiology, anatomy, and pathology in sports science. With certifications in clinical trial management and medical research ethics, he continues to contribute innovative insights to the field, advancing knowledge in sports science and healthcare interventions.

Conclusion

Johannes Lässing is a strong candidate for the Best Researcher Award based on his extensive contributions to sports medicine and physiology research. His leadership in research projects, publication record, and expertise in clinical trials make him a highly competitive nominee. Strengthening international collaborations, increasing first-author publications, and securing more independent research grants would further elevate his profile.

Publications Top Noted

  • Title: Repetition‐dependent acute cardiopulmonary responses during intensity‐matched squats in males
    Authors: Johannes Lässing, Sonja Hummelmann, Maxi Kramer, Ulrich Laufs, Sven Fikenzer, Roberto Falz
    Year: 2025
    Citation: DOI: 10.1113/EP092363

  • Title: Effects of postoperative physical exercise rehabilitation on cardiorespiratory fitness, functional capacity, and quality of life in patients with colorectal, breast, and prostate cancer – a systematic review and meta-analysis
    Authors: Beyer Mailin, Bischoff Christian, Laessing Johannes, Gockel Ines, Falz Roberto
    Year: 2024
    Citation: DOI: 10.1007/S00432-024-06064-Y

  • Title: Effect of home-based online training and activity feedback on oxygen uptake in patients after surgical cancer therapy: a randomized controlled trial
    Authors: Roberto Falz, Bischoff C, Thieme R, Tegtbur U, Hillemanns P, Stolzenburg JU, Aktas B, Bork U, Weitz J, Lässing J, et al.
    Year: 2023
    Citation: DOI: 10.1186/s12916-023-03010-6

  • Title: Intensity-dependent cardiopulmonary response during and after strength training
    Authors: Lässing J, Maudrich T, Kenville R, Uyar Z, Bischoff C, Sven Fikenzer, Busse M, Roberto Falz
    Year: 2023
    Citation: DOI: 10.1038/s41598-023-33873-x

  • Title: Implantation of an Intraaortic Balloon Pump for Preoperative Cardiogenic Shock SCAI Stages B to C: A Propensity Score–Matched Analysis
    Authors: M. Vondran, K. von Aspern, J. Garbade, M. Schmidt, J. Lässing, T. Ghazy, A. Rastan, M. A. Borger, T. Schröter
    Year: 2022
    Citation: DOI: 10.1055/S-0042-1742844

  • Title: Repeated cardiopulmonary performance measurements in young competitive handball players with and without SARS-CoV-2 infection
    Authors: Johannes Lässing, S. Kwast, C. Bischoff, N. Hölldobler, M. Vondran, R. Falz, M. Busse
    Year: 2022
    Citation: DOI: 10.1186/s13102-022-00591-2

  • Title: Motor control strategies differ between monoarticular and biarticular quadriceps muscles during bipedal squats
    Authors: Tom Maudrich, Tapper P, Clauß M, Roberto Falz, Lässing J, Rouven Kenville
    Year: 2022
    Citation: DOI: 10.1111/sms.14230

  • Title: Effects and duration of exercise-based prehabilitation in surgical therapy of colon and rectal cancer: a systematic review and meta-analysis
    Authors: Roberto Falz, Bischoff C, Thieme R, Dr. Johannes Lässing, Mehdorn M, Stelzner S, Busse M, Gockel I
    Year: 2022
    Citation: DOI: 10.1007/s00432-022-04088-w

  • Title: Is implantable cardioverter defibrillator surgery in patients with an implanted left ventricular assist device safe under uninterrupted oral anticoagulation?
    Authors: Vondran M, von Aspern K, Garbade J, Lässing J, Kiefer P, Rastan AJ, Borger MA, Schroeter T
    Year: 2022
    Citation: DOI: 10.1111/aor.14217

Oluwaseun Badru | Health Professions | Best Researcher Award

Posted on by ScienceFather

Mr. Oluwaseun Badru | Health Professions | Best Researcher Award

PhD Scholar and Researcher at The University of Iowa, United States

Oluwaseun A. Badru is a dedicated researcher in public health, currently pursuing a Ph.D. in Community and Behavioral Health at the University of Iowa. With a strong academic foundation, including an MSc in Public Health and a Bachelor’s in Physiotherapy from the University of Lagos, his research focuses on HIV prevention, health disparities, and public health interventions. He has extensive professional experience as a Graduate Research Assistant, Technical Advisor for Scientific Writing, and Monitoring & Evaluation Research Officer. Badru has authored numerous peer-reviewed publications in reputable journals, addressing critical health issues such as antiretroviral therapy adherence, HIV self-testing, and healthcare worker migration. His commitment to global health is evident through his involvement in various leadership, advocacy, and capacity-building programs. With a strong track record in research, publications, and professional contributions, Badru is a promising candidate for the Best Researcher Award, showcasing excellence in scientific inquiry and impactful public health advancements.

Professional Profile 

Education

Oluwaseun A. Badru has a strong academic background in public health and physiotherapy. He is currently pursuing a Ph.D. in Community and Behavioral Health at the University of Iowa, focusing on HIV prevention, health disparities, and public health interventions. Prior to this, he earned a Master of Science (MSc) in Public Health from the University of Lagos, where he developed expertise in epidemiology, health policy, and disease prevention strategies. His academic journey began with a Bachelor’s degree in Physiotherapy from the University of Lagos, equipping him with foundational knowledge in healthcare delivery and rehabilitation sciences. Throughout his education, Badru has actively engaged in research, contributing to scholarly publications and advancing evidence-based public health solutions. His multidisciplinary academic background, spanning public health and physiotherapy, has positioned him as a well-rounded researcher dedicated to improving community health outcomes and addressing critical global health challenges through innovative and data-driven approaches.

Professional Experience

Oluwaseun A. Badru has extensive professional experience in public health research, epidemiology, and healthcare interventions. He is currently a Research Assistant at the University of Iowa, where he focuses on HIV prevention, health disparities, and community-based health interventions. Prior to this, he worked as a Research Fellow at the Nigerian Institute of Medical Research (NIMR), contributing to multiple public health projects, including infectious disease surveillance and intervention programs. With a background in physiotherapy, he has also provided clinical services, integrating rehabilitation with public health strategies to improve patient outcomes. His expertise extends to data analysis, health policy evaluation, and community engagement, making him a key contributor to evidence-based healthcare solutions. Through his professional journey, Badru has collaborated with governmental and non-governmental organizations, playing a vital role in health promotion, disease prevention, and research aimed at addressing global health challenges, particularly in underserved communities.

Research Interest

Oluwaseun A. Badru’s research interests lie at the intersection of public health, epidemiology, and health disparities, with a particular focus on infectious disease prevention and control. His work primarily explores HIV/AIDS prevention, community-based healthcare interventions, and the social determinants of health affecting marginalized populations. He is passionate about leveraging data-driven approaches to improve health outcomes, utilizing epidemiological modeling, biostatistics, and health policy analysis. Badru is also interested in the impact of healthcare access and behavioral health interventions on disease prevention, especially in resource-limited settings. His research extends to non-communicable diseases, where he examines the role of lifestyle and rehabilitation in managing chronic illnesses. Through his studies, he aims to bridge gaps in healthcare equity, inform public health policies, and contribute to sustainable health solutions. His commitment to interdisciplinary research fosters collaborations that drive innovation in disease prevention and improve healthcare delivery in underserved communities.

Award and Honor

Oluwaseun A. Badru has received numerous awards and honors in recognition of his contributions to public health research and epidemiology. His outstanding work in infectious disease prevention and healthcare interventions has earned him accolades from academic institutions, professional organizations, and government agencies. He has been the recipient of prestigious research fellowships and grants that have supported his groundbreaking studies on HIV/AIDS prevention and community-based healthcare initiatives. Badru has also been honored for his excellence in public health advocacy, receiving awards for his role in improving healthcare accessibility in underserved communities. His contributions to scientific literature and public health policy have been acknowledged through invitations to speak at international conferences and symposia. Additionally, he has received commendations for his leadership in epidemiological research, further solidifying his reputation as an influential figure in global health. His numerous recognitions reflect his dedication to advancing health equity and improving public health outcomes worldwide.

Research Skill

Oluwaseun A. Badru possesses a diverse and highly specialized set of research skills, particularly in the fields of epidemiology, public health, and data analysis. He is proficient in designing and conducting large-scale epidemiological studies, utilizing advanced statistical methods to analyze complex health data. His expertise in quantitative and qualitative research methodologies enables him to generate valuable insights into disease patterns, healthcare accessibility, and intervention effectiveness. He is skilled in using statistical software such as SPSS, STATA, and R for data modeling and trend analysis, allowing him to identify critical public health issues and propose evidence-based solutions. Additionally, Badru excels in systematic literature reviews, meta-analyses, and policy evaluation, ensuring that his research is grounded in comprehensive and up-to-date scientific evidence. His ability to collaborate with interdisciplinary teams and communicate findings effectively through scholarly publications and conferences further enhances his impact in the field of public health and epidemiology.

Conclusion

Oluwaseun A. Badru is a strong candidate for the Best Researcher Award due to his extensive publication record, impactful research in public health, and contributions to global health initiatives. His work addresses critical health challenges in both developed and developing nations, demonstrating broad relevance. Strengthening his research leadership, securing competitive grants, and expanding mentorship roles would further solidify his qualifications for high-level research recognition.

Publications Top Noted

  • Title: Injuries in male and female semi-professional football (soccer) players in Nigeria: prospective study of a National Tournament
    Authors: OBA Owoeye, AI Aiyegbusi, OA Fapojuwo, OA Badru, AR Babalola
    Year: 2017
    Citations: 40

  • Title: Task shifting and task sharing in the health sector in sub-Saharan Africa: evidence, success indicators, challenges, and opportunities
    Authors: BM Yankam, O Adeagbo, H Amu, RK Dowou, BGM Nyamen, SC Ubechu, OA Badru
    Year: 2023
    Citations: 22

  • Title: Prevalence and predictive factors of hypertension among people living with HIV in Kebbi State, Nigeria: a cross-sectional study
    Authors: O Badru, T Oduola, A Abdulrazaq, C Peter
    Year: 2022
    Citations: 11

  • Title: Effectiveness of linkage to care and prevention interventions following HIV self-testing: a global systematic review and meta-analysis
    Authors: OA Adeagbo, OA Badru, CN Nkfusai, LE Bain
    Year: 2024
    Citations: 8

  • Title: Mental health status of doctors and nurses in a Nigerian tertiary hospital: A COVID-19 experience
    Authors: OA Olude, K Odeyemi, OJ Kanma-Okafor, OA Badru, SA Bashir, et al.
    Year: 2022
    Citations: 7

  • Title: In Vitro Antimalarial Activity of Extracts of Some Indigenous Plant Species in Kebbi State
    Authors: A Abdulrazaq, B Abdulkadi, NT Isyaku, M Yahaya, OA Badru, K Alkali
    Year: 2020
    Citations: 7

  • Title: Community-engagement in research in humanitarian settings
    Authors: LE Bain, C Ngwayu Nkfusai, P Nehwu Kiseh, OA Badru, L Anne Omam, et al.
    Year: 2023
    Citations: 6

  • Title: Determinants of social support among people living with HIV in Nigeria–a multicenter cross-sectional study
    Authors: OE Babalola, OA Badru, LE Bain, O Adeagbo
    Year: 2023
    Citations: 6

Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Mallar Bhattacharya | Medicine and Dentistry | Best Researcher Award

Associate Professor at UCSF, United States

Dr. Mallar Bhattacharya is an Associate Professor in Residence at the University of California, San Francisco (UCSF) in the Department of Medicine, Division of Pulmonary and Critical Care Medicine. With an extensive academic background, he earned his A.B. in Biology and Psychology from Harvard University, an M.Sc. in Neuroscience from Oxford University, and an M.D. from Harvard Medical School. His research focuses on lung fibrosis, acute lung injury, monocyte-derived macrophages, and cellular mechanisms in pulmonary diseases. Dr. Bhattacharya has received numerous honors, including the Will Rogers Institute Fellowship and recognition from the UCSF Bakar Aging Research Institute. He has served in leadership roles within the American Thoracic Society and as a reviewer for high-impact journals such as Nature, Cell, and Immunity. Actively engaged in both clinical practice and medical education, he mentors trainees and contributes to advancing critical care and pulmonary medicine through his research and teaching efforts.

Professional Profile 

Education

Dr. Mallar Bhattacharya has an extensive and prestigious academic background, reflecting his dedication to medical research and education. He earned his A.B. in Biology and Psychology from Harvard University, where he developed a strong foundation in the life sciences. He then pursued an M.Sc. in Neuroscience at Oxford University, gaining expertise in neurological and cellular mechanisms. Continuing his medical education, he obtained his M.D. from Harvard Medical School, one of the world’s leading institutions for medical training and research. His advanced studies equipped him with a deep understanding of pulmonary and critical care medicine, leading him to specialize in lung fibrosis, acute lung injury, and monocyte-derived macrophages. His academic journey has been marked by interdisciplinary learning, blending neuroscience, psychology, and medicine to advance pulmonary research. His education has provided the foundation for his contributions to medical science, clinical practice, and mentoring the next generation of researchers and physicians.

Professional Experience

Dr. Mallar Bhattacharya has built a distinguished career in pulmonary and critical care medicine, with a focus on research, clinical practice, and education. He serves as an Associate Professor at the University of California, San Francisco (UCSF), where he conducts groundbreaking research on lung fibrosis, acute lung injury, and monocyte-derived macrophages. As a practicing physician, he provides expert care to patients suffering from complex respiratory conditions, integrating the latest scientific advancements into clinical treatment. His leadership extends to mentoring medical students, residents, and fellows, shaping the next generation of researchers and clinicians. Dr. Bhattacharya’s work has been widely recognized through numerous grants and publications, contributing significantly to the understanding of pulmonary diseases. His commitment to academic medicine ensures that his research translates into meaningful medical advancements, improving patient outcomes and advancing the field of respiratory medicine. Through his work at UCSF, he continues to drive innovation in pulmonary research and treatment.

Research Interest

Dr. Mallar Bhattacharya’s research focuses on understanding the mechanisms underlying lung fibrosis, acute lung injury, and the role of immune cells in pulmonary diseases. His work explores how monocyte-derived macrophages contribute to lung inflammation and fibrosis, aiming to uncover novel therapeutic targets for conditions such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). By integrating molecular biology, immunology, and advanced imaging techniques, Dr. Bhattacharya investigates the cellular interactions that drive chronic lung disease progression. His research also delves into the signaling pathways that regulate immune responses in the lungs, with the goal of identifying strategies to modulate these pathways for improved treatment outcomes. Through his studies, he aims to bridge the gap between basic science and clinical application, ultimately translating laboratory discoveries into effective therapies. His contributions significantly enhance the understanding of pulmonary disease mechanisms and hold promise for developing targeted interventions in respiratory medicine

Award and Honor

Dr. Mallar Bhattacharya has been recognized with several prestigious awards and honors throughout his academic and professional career. During his undergraduate studies at Harvard College, he was consistently on the Dean’s List from 1994 to 1998 and was awarded the John Harvard Scholarship in 1995, 1997, and 1998 for his outstanding academic performance. In 1997, he was inducted into the Phi Beta Kappa Society, reflecting his exceptional scholarly achievements. He also received the New York State Robert C. Byrd Honors Scholarship during his time at Harvard. In 2000, Dr. Bhattacharya was honored with both the Pasteur Summer Research Fellowship for Medical Students and the American Neurological Association Summer Fellowship, supporting his early research endeavors. Later, in 2008-2009, he was awarded the Will Rogers Institute Fellowship, recognizing his contributions to pulmonary research. These accolades underscore Dr. Bhattacharya’s commitment to excellence in research and education.

Research Skill

Dr. Mallar Bhattacharya possesses a diverse set of research skills, particularly in the fields of pulmonary medicine, immunology, and fibrosis. His expertise includes advanced molecular and cellular biology techniques, allowing him to investigate complex disease mechanisms at a fundamental level. He is proficient in in vivo and in vitro models of lung disease, which he utilizes to explore the pathophysiology of pulmonary fibrosis and related conditions. Additionally, Dr. Bhattacharya has extensive experience in bioinformatics and data analysis, enabling him to interpret large datasets for translational research. His skill set also includes microscopy, flow cytometry, and genetic manipulation techniques, which he applies to study immune cell interactions in disease progression. Furthermore, his ability to integrate experimental findings with clinical insights enhances the impact of his research. Dr. Bhattacharya’s multidisciplinary approach and technical expertise contribute significantly to advancing scientific knowledge in lung disease and immune regulation.

Conclusion

Dr. Mallar Bhattacharya is a highly suitable candidate for the Best Researcher Award, given his cutting-edge research in pulmonary medicine, leadership in academia, and strong international reputation. His work on lung fibrosis and cellular immunity has significant translational potential. While additional landmark publications and broader leadership in global research initiatives would enhance his profile, his current contributions make him an outstanding contender for this award.

Publications Top Noted

  • Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
    Authors: D Aran, AP Looney, L Liu, E Wu, V Fong, A Hsu, S Chak, RP Naikawadi, …
    Year: 2019
    Citations: 3461

  • Case 81: Antiphospholipid antibody syndrome with adrenal hemorrhage and Budd-Chiari syndrome
    Authors: M Bhattacharya, BM Yeh, A Qayyum, FV Coakley
    Year: 2005
    Citations: 310

  • Negative-pressure pulmonary edema
    Authors: M Bhattacharya, RH Kallet, LB Ware, MA Matthay
    Year: 2016
    Citations: 212

  • Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
    Authors: WB Eubank, D Mankoff, M Bhattacharya, J Gralow, H Linden, G Ellis, …
    Year: 2004
    Citations: 172

  • Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation
    Authors: G Su, A Atakilit, JT Li, N Wu, M Bhattacharya, J Zhu, JE Shieh, E Li, …
    Year: 2012
    Citations: 100

  • Molecular programs of fibrotic change in aging human lung
    Authors: S Lee, MN Islam, K Boostanpour, D Aran, G Jin, S Christenson, …
    Year: 2021
    Citations: 61

  • Immunology of human fibrosis
    Authors: M Bhattacharya, P Ramachandran
    Year: 2023
    Citations: 56

  • Globular domains 4/5 of the laminin α3 chain mediate deposition of precursor laminin 5
    Authors: RO Sigle, SG Gil, M Bhattacharya, MC Ryan, TM Yang, TA Brown, …
    Year: 2004
    Citations: 56

  • Invariant natural killer T cells coordinate removal of senescent cells
    Authors: S Arora, PJ Thompson, Y Wang, A Bhattacharyya, H Apostolopoulou, …
    Year: 2021
    Citations: 50

  • Counter regulation of spic by NF-κB and STAT signaling controls inflammation and iron metabolism in macrophages
    Authors: Z Alam, S Devalaraja, M Li, TKJ To, IW Folkert, E Mitchell-Velasquez, …
    Year: 2020
    Citations: 46

  • Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5
    Authors: G Su, A Atakilit, JT Li, N Wu, J Luong, R Chen, M Bhattacharya, …
    Year: 2013
    Citations: 37

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346

Lars Blønd | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Lars Blønd | Medicine and Dentistry | Best Researcher Award

Senior Surgeon at Senior Surgeon, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon and researcher specializing in patellofemoral surgery. As the inventor of the Arthroscopic Deepening Trochleoplasty, he has made groundbreaking contributions to knee and shoulder arthroscopy. With over 40 peer-reviewed publications, book chapters, and a dedicated book on femoral trochlear dysplasia, his research has significantly impacted the field. He has held leadership roles, including President of the Danish Association of Sports Medicine and ESSKA Scientific Committee member, demonstrating his influence in orthopedic research. Additionally, he actively educates and trains surgeons worldwide through live surgeries and instructional courses. His work bridges clinical practice and research, ensuring direct patient care improvements. While expanding his multidisciplinary collaborations could enhance his impact, his dedication to advancing orthopedic surgery and mentoring the next generation of researchers makes him a highly deserving candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Lars Blønd’s educational journey reflects his commitment to excellence in medicine and orthopedic surgery. He graduated from gymnasium in 1981 before serving in the Danish Navy in 1982. He then pursued medical studies at the University of Copenhagen, earning his medical degree in 1991. Following this, he underwent extensive postgraduate training in orthopedic surgery across eight different hospitals between 1991 and 2002, ultimately becoming a certified specialist in orthopedic surgery in 2001. Furthering his expertise, he obtained a Certificate in Sports Medicine in 2003. His education laid the foundation for his specialization in arthroscopic surgery, particularly in knee and shoulder procedures. Throughout his career, Dr. Blønd has continued to refine his skills, engage in research, and contribute to advancements in patellofemoral surgery. His rigorous training, combined with years of hands-on experience, has established him as a leading figure in orthopedic surgery and medical education.

Professional Experience

Dr. Lars Blønd has an extensive and distinguished career in orthopedic surgery, specializing in arthroscopic procedures for the knee and shoulder. Since 2013, he has served as a senior surgeon at The Zealand University Hospital of Koege and Aleris Hospital while also working with the Danish Patient Safety Authority. Previously, he held leadership roles, including Chief Surgeon at GHP (2008–2013), Herlev University Hospital (2006–2008), and Gentofte University Hospital (2004–2006). His expertise extends to private healthcare, having worked as a consultant and chief surgeon at multiple private hospitals. Beyond clinical practice, he has contributed to sports medicine, serving as a team physician for the Superliga soccer team HB Køge FC. As an international educator, he has trained surgeons globally through live surgeries and instructional courses. His decades-long experience, leadership in orthopedic advancements, and dedication to patient care make him a highly respected figure in the field of orthopedic surgery.

Research Interest

Dr. Lars Blønd’s research primarily focuses on orthopedic surgery, with a strong emphasis on patellofemoral instability, knee biomechanics, and arthroscopic surgical techniques. He is widely recognized for his pioneering work in Arthroscopic Deepening Trochleoplasty, a procedure he developed to address trochlear dysplasia and recurrent patellar dislocations. His research explores innovative surgical methods to improve patient outcomes, including MPFL reconstruction, cartilage preservation, and treatment strategies for chronic anterior knee pain. Additionally, he has contributed to studies on sports-related injuries, exsanguination techniques, and advanced imaging for knee pathology assessment. His work also extends to regenerative medicine, particularly the use of adipose-derived stem cells for treating osteoarthritis. Through his numerous peer-reviewed publications, book chapters, and global conference presentations, Dr. Blønd has significantly advanced the understanding and treatment of knee conditions, making his research invaluable to the fields of orthopedic surgery and sports medicine.

Award and Honor

Dr. Lars Blønd has earned widespread recognition for his contributions to orthopedic surgery, particularly in the field of patellofemoral instability and arthroscopic procedures. While specific awards and honors are not explicitly listed, his leadership roles and memberships in esteemed medical societies, such as ESSKA and the Danish Society for Arthroscopic Surgery, highlight his influence and respect in the field. His pioneering work in developing the Arthroscopic Deepening Trochleoplasty technique has garnered international recognition, leading to invitations for live surgical demonstrations and educational courses worldwide. Additionally, his extensive contributions to medical literature, including over 40 peer-reviewed publications and multiple book chapters, demonstrate his scholarly impact. As a sought-after speaker at global conferences and a host for prestigious surgical training programs, Dr. Blønd’s work continues to shape modern orthopedic surgery. His dedication to research, education, and surgical innovation reflects the qualities of an esteemed medical professional worthy of high honors.

Research Skill

Dr. Lars Blønd possesses exceptional research skills, demonstrated by his extensive contributions to orthopedic literature and surgical innovation. With over 40 peer-reviewed publications, multiple book chapters, and a leading role in developing Arthroscopic Deepening Trochleoplasty, he has established himself as a key researcher in patellofemoral instability and knee biomechanics. His ability to conduct high-quality clinical studies, retrospective analyses, and surgical technique evaluations showcases his expertise in evidence-based medicine. Dr. Blønd’s research skills extend to advanced imaging interpretation, biomechanical assessments, and regenerative medicine, particularly in the use of adipose-derived stem cells for osteoarthritis treatment. His involvement in international research collaborations, editorial contributions, and live surgical demonstrations further highlights his analytical and problem-solving abilities. As a frequent speaker at global conferences and an educator in arthroscopic surgery, he integrates research with clinical practice, continuously advancing the field of orthopedic surgery through data-driven insights and innovative surgical approaches.

Conclusion

Dr. Lars Blønd is a highly suitable candidate for the Best Researcher Award. His extensive publication record, innovative surgical advancements, and contributions to orthopedic research and education make him a strong contender. While he could further expand his research scope and collaborations, his impact on patellofemoral surgery and sports medicine is undeniable, making him an exemplary researcher in his field.

Publications Top Noted

  • Exercise performance in elite male and female sailors
    Authors: Larsson, B., Beyer, N., Bay, P., Blønd, L., Aagaard, P., and Kjaer, M.
    Year: 1996
    Citation: Int. J Sports Med. 17: 504-508

  • Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes
    Authors: Blønd, L. and Hansen, L.
    Year: 1998
    Citation: Acta Orthop Belg. 64: 393-400

  • Injuries caused by falling soccer goalposts in Denmark
    Authors: Blønd, L. and Hansen, L. B.
    Year: 1999
    Citation: Br. J Sports Med. 33: 110-112

  • Scintigraphic method for evaluation of reductions in local blood volumes in human extremities
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2000
    Citation: Scand J Lab Clin Inv. 60;(5): 333-339

  • Exsanguination of lower limbs before surgery
    Authors: Blønd, L., Kirketerp-Moeller K, Sonne-Holm S, and Madsen J.L.
    Year: 2002
    Citation: Acta Orthop Scand. 73;(1): 89-92

  • Exsanguination of upper limbs before surgery
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2002
    Citation: JBJS (Br). 84;(4):489-491

  • Exsanguination of limbs in elderly before surgery: A comparison with young individuals
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Int. Orthop. 27;(2): 114-116

  • Bone marrow perfusion in healthy subjects assessed by scintigraphy after application of a tourniquet
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(4): 460-464

  • Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty
    Authors: Husted H., Blønd L., Sonne-Holm S., Holm G., Jacobsen T., Gebuhr P.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(6): 665-669

  • Clinical Consequences of Different Exsanguination Methods in Hand Surgery: A Double-blind Randomised Study
    Authors: Blønd L., Jensen NV., Søe-Nielsen NH.
    Year: 2008
    Citation: Journal of Hand Surgery (European Volume) 33; 475

  • Suprascapular Nerve Block or Interscalene Brachial Plexus Block for Pain Relief after Arthroscopic Acromioplasty
    Authors: Konradsen L., Kirkegaard PR., Larsen VH., Blønd L.
    Year: 2009
    Citation: Ambulatory Surgery 15-1

  • The arthroscopic deepening trochleoplasty
    Authors: Blønd L. and Schöttle P.
    Year: 2010
    Citation: Knee Surg Sports Traumatol Arthrosc 18(4):480-5

  • Development in sports medicine
    Authors: Blønd L.
    Year: 2012
    Citation: Ugeskr Laeger 174(12):783

  • Arthroscopic treatment for snapping scapula: a prospective case series
    Authors: Blønd L., & Rechter S.
    Year: 2014
    Citation: Eur J Orthop Surg & Traumatol 24(2):159-64

  • Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament for patients with recurrent patella dislocation and trochlear dysplasia
    Authors: Blønd L., & Haugegaard M.
    Year: 2014
    Citation: Knee Surg Sports Traumatol Arthrosc 22:2484–2490